Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease
- PMID: 38421123
- PMCID: PMC11032581
- DOI: 10.1002/alz.13733
Entorhinal-based path integration selectively predicts midlife risk of Alzheimer's disease
Abstract
Introduction: Entorhinal cortex (EC) is the first cortical region to exhibit neurodegeneration in Alzheimer's disease (AD), associated with EC grid cell dysfunction. Given the role of grid cells in path integration (PI)-based spatial behaviors, we predicted that PI impairment would represent the first behavioral change in adults at risk of AD.
Methods: We compared immersive virtual reality (VR) PI ability to other cognitive domains in 100 asymptomatic midlife adults stratified by hereditary and physiological AD risk factors. In some participants, behavioral data were compared to 7T magnetic resonance imaging (MRI) measures of brain structure and function.
Results: Midlife PI impairments predicted both hereditary and physiological AD risk, with no corresponding multi-risk impairment in episodic memory or other spatial behaviors. Impairments associated with altered functional MRI signal in the posterior-medial EC.
Discussion: Altered PI may represent the transition point from at-risk state to disease manifestation in AD, prior to impairment in other cognitive domains.
Keywords: Alzheimer's disease; entorhinal cortex; path integration; preclinical; virtual reality.
© 2024 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
The authors have no conflicts of interest (see supporting information).
Figures



Update of
-
Path integration selectively predicts midlife risk of Alzheimer's disease.bioRxiv [Preprint]. 2023 Feb 3:2023.01.31.526473. doi: 10.1101/2023.01.31.526473. bioRxiv. 2023. Update in: Alzheimers Dement. 2024 Apr;20(4):2779-2793. doi: 10.1002/alz.13733. PMID: 36778428 Free PMC article. Updated. Preprint.
References
-
- Wittenberg R, Hu B, Barraza‐Araiza LF, Rehill A, Projections of Older People with Dementia and Costs of Dementia Care in the United Kingdom, 2019‐2040. 2019.
-
- Stomrud E, Minthon L, Zetterberg H, Blennow K, Hansson O. Longitudinal cerebrospinal fluid biomarker measurements in preclinical sporadic Alzheimer's disease: a prospective 9‐year study. Alzheimer's and Dementia: diagnosis. Assess Dis Monit. 2015;1:403‐411. doi:10.1016/j.dadm.2015.09.002 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous